|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
1UH2CA213385-01
|
$25,705
|
$25,705
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting PML for Leukemia Therapy
|
2R01CA142874-06A1
|
$465,791
|
$465,791
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
4R01CA155091-05
|
$317,475
|
$317,475
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
4R00CA181488-03
|
$249,000
|
$249,000
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
|
Adult Leukemia Research Center
|
4P01CA018029-41
|
$4,225,448
|
$169,018
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S1
|
$78,024
|
$780
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S2
|
$249,999
|
$2,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S3
|
$125,000
|
$1,250
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S4
|
$60,000
|
$600
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S5
|
$209,966
|
$2,100
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S6
|
$500,000
|
$5,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-41S7
|
$749,998
|
$7,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-41
|
$9,561,228
|
$95,612
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
4R01CA175215-04
|
$585,953
|
$585,953
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-13S1
|
$106,561
|
$106,561
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-13
|
$307,800
|
$307,800
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
|
2R13CA132568-10
|
$5,000
|
$5,000
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
4R01CA160433-05
|
$336,150
|
$336,150
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
4P01CA015396-41
|
$1,853,411
|
$92,671
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S1
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S2
|
$114,211
|
$1,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S3
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
4P30CA006973-53
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of TET proteins in myeloid malignancies
|
4R01CA151535-05
|
$370,180
|
$370,180
|
RAO, ANJANA
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
Improving targeted therapies through functional genomic approaches
|
5F31CA189437-02
|
$43,576
|
$43,576
|
WANG, TIM
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cytotoxicity of MLN4924 in Acute Myeloid Leukemia
|
5F30CA183507-03
|
$42,276
|
$21,138
|
KNORR, KATHERINE
|
MAYO CLINIC ROCHESTER
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-03
|
$650,528
|
$650,528
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Natural History Study of the Complications Associated with Allogeneic HCT
|
ZIA BC 011742
|
$369,153
|
$36,915
|
Gea-Banacloche, Juan
|
CCR (NCI)
|
|
Molecular-Cellular Regulation of Hematopoiesis
|
ZIA BC 010001
|
$804,994
|
$201,249
|
Keller, Jonathan
|
CCR (NCI)
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$896,475
|
$89,647
|
Larson, Daniel
|
CCR (NCI)
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$403,118
|
$100,780
|
Tosato, Giovanna
|
CCR (NCI)
|
|
The role of Sin3B in normal and malignant hematopoietic stem cell functions
|
1F30CA203047-01
|
$48,576
|
$48,576
|
CANTOR, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
4R01CA101774-14
|
$303,965
|
$303,965
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
4R01CA174205-04
|
$320,588
|
$320,588
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-02
|
$2,074,472
|
$954,257
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
$3,179
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
$8,099
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
$194,607
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Signal Transduction of Type 1 Interferons in Malignant Cells
|
4R01CA077816-18
|
$298,913
|
$298,913
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Development of novel therapies for megakaryocytic malignancies
|
1R50CA211534-01
|
$129,512
|
$129,512
|
WEN, QIANG
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
|
5R00CA151670-05
|
$248,246
|
$248,246
|
AGARWAL, ANUPRIYA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S3
|
$1,479,340
|
$73,967
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S4
|
$124,995
|
$6,250
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S5
|
$749,999
|
$37,500
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S6
|
$60,000
|
$3,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
|
4R00CA190605-03
|
$248,998
|
$248,998
|
MAXSON, JULIA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
|
5R01CA183974-03
|
$319,550
|
$319,550
|
TYNER, JEFFREY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
1K22CA190674-01A1
|
|
$0
|
BARTH, BRIAN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
4R01CA044722-26
|
$203,601
|
$101,801
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Molecular Pathogenesis and Therapy of ET and PMF
|
2R01CA151949-06
|
$407,075
|
$407,075
|
LEVINE, ROSS
|
SLOAN-KETTERING INST CAN RESEARCH
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $21,275,150
|